Govt in talks with SII for Nipah antibody, may put imports on hold

Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum......

Why WHO suspended supply of Covaxin through UN agencies

Sources close to the development said the company had no further supply commitments to the WHO, and therefore, there was no suspension of any upcoming orders, reports Sohini Das.  Bharat......

Trust Indian industry: WHO on delay in Covaxin nod

India's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the World Health......

Serum Institute seeks regular marketing approval for Covishield

Pointing out that over 100 crore doses of Covishield have been supplied in India and many other countries, Serum Institute of India on Monday sought regular marketing approval for the COVID-19......

Serum Institute's race to produce COVID-19 vaccine

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......

Serum Institute to produce COVID-19 vaccine by yearend

'The challenge will be making sure its efficacy is high.''If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.' Adar Poonawalla, chief executive officer, Serum Institute of......

Cipla heir apparent Kamil steps down

Kamil is the son of M K Hamied, who is the brother of Cipla’s non-executive chairman, Yusuf Hamied In a surprise move, Kamil Hamied (photographed below), successor of the Hamied family in......

A peek into the flashy lifestyles of India's richest businessmen

Indian billionaires do not believe in sitting on their wealth. They'd rather go out and a buy a plane or two, or an expensive car, or maybe a horse. Here's a look at the lifestyles and interests of......